SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:df76abf0-cd9b-420e-a934-3768d23e0f88"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:df76abf0-cd9b-420e-a934-3768d23e0f88" > Association between...

Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes : A meta-analysis

Lotta, Luca A. (författare)
University of Cambridge,National Institute for Public Health and the Environment (RIVM)
Sharp, Stephen J. (författare)
University of Cambridge
Burgess, Stephen (författare)
University of Cambridge
visa fler...
Perry, John R B (författare)
University of Cambridge,University of Paris-Saclay
Stewart, Isobel D. (författare)
University of Cambridge
Willems, Sara M. (författare)
University of Cambridge
Luan, Jian'an (författare)
University of Cambridge
Ardanaz, Eva (författare)
Health Research Institute of Navarra (IDISNA),CIBER Epidemiology and Public Health (CIBERESP)
Arriola, Larraitz (författare)
Centre for Research in Epidemiology and Population Health (CESP)
Balkau, Beverley (författare)
University of Paris-Saclay,University of Cambridge
Boeing, Heiner (författare)
German Institute of Human Nutrition
Deloukas, Panos (författare)
Wellcome Trust Sanger Institute
Forouhi, Nita G. (författare)
University of Cambridge
Franks, Paul W. (författare)
Umeå universitet,Umeå University,Lund University,Lunds universitet,Genetisk och molekylär epidemiologi,Forskargrupper vid Lunds universitet,Genetic and Molecular Epidemiology,Lund University Research Groups,Medicin,Skane University Hospital, Malmö, Sweden
Grioni, Sara (författare)
University of Milan
Kaaks, Rudolf (författare)
German Cancer Research Centre
Key, Timothy J. (författare)
University of Oxford
Navarro, Carmen (författare)
Murcia Regional Health Council,University of Murcia
Nilsson, Peter M. (författare)
Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups
Overvad, Kim (författare)
Aalborg University Hospital,Aarhus University
Palli, Domenico (författare)
Cancer Research and Prevention Institute (ISPO)
Panico, Salvatore (författare)
University of Naples Federico II
Quirós, Jose Ramón (författare)
Public Health Directorate
Riboli, Elio (författare)
Imperial College London
Rolandsson, Olov (författare)
Umeå universitet,Umeå University,Allmänmedicin
Sacerdote, Carlotta (författare)
Human Genetics Foundation (HuGeF),Citta' della Salute e della Scienza Hospital-University of Turin
Salamanca-Fernandez, Elena (författare)
Andalusian School Of Public Health (EASP),CIBER Epidemiology and Public Health (CIBERESP)
Slimani, Nadia (författare)
International Agency for Research on Cancer, World Health Organization
Spijkerman, Annemieke M W (författare)
National Institute for Public Health and the Environment (RIVM)
Tjonneland, Anne (författare)
Danish Cancer Society
Tumino, Rosario (författare)
Civic and M.P Arezzo Hospital
Van Der A, Daphne L. (författare)
National Institute for Public Health and the Environment (RIVM)
Van Der Schouw, Yvonne T. (författare)
University Medical Center Utrecht
McCarthy, Mark I. (författare)
University of Oxford
Barroso, Inês (författare)
Wellcome Trust Sanger Institute
O'Rahilly, Stephen (författare)
University of Cambridge
Savage, David B. (författare)
University of Cambridge
Sattar, Naveed (författare)
University of Glasgow
Langenberg, Claudia (författare)
University of Cambridge
Scott, Robert A. (författare)
University of Cambridge
Wareham, Nicholas J. (författare)
University of Cambridge
visa färre...
 (creator_code:org_t)
American Medical Association (AMA), 2016
2016
Engelska 9 s.
Ingår i: JAMA: The Journal of the American Medical Association. - : American Medical Association (AMA). - 0098-7484 .- 1538-3598. ; 316:13, s. 1383-1391
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • IMPORTANCE Low-density lipoprotein cholesterol (LDL-C)-lowering alleles in or near NPC1L1 or HMGCR, encoding the respective molecular targets of ezetimibe and statins, have previously been used as proxies to study the efficacy of these lipid-lowering drugs. Alleles near HMGCR are associated with a higher risk of type 2 diabetes, similar to the increased incidence of new-onset diabetes associated with statin treatment in randomized clinical trials. It is unknown whether alleles near NPC1L1 are associated with the risk of type 2 diabetes. OBJECTIVE To investigate whether LDL-C-lowering alleles in or near NPC1L1 and other genes encoding current or prospective molecular targets of lipid-lowering therapy (ie, HMGCR, PCSK9, ABCG5/G8, LDLR) are associated with the risk of type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS The associations with type 2 diabetes and coronary artery disease of LDL-C-lowering genetic variants were investigated in meta-analyses of genetic association studies. Meta-analyses included 50 775 individuals with type 2 diabetes and 270 269 controls and 60 801 individuals with coronary artery disease and 123 504 controls. Data collection took place in Europe and the United States between 1991 and 2016. EXPOSURES Low-density lipoprotein cholesterol-lowering alleles in or near NPC1L1, HMGCR, PCSK9, ABCG5/G8, and LDLR. MAIN OUTCOMES AND MEASURES Odds ratios (ORs) for type 2 diabetes and coronary artery disease. RESULTS Low-density lipoprotein cholesterol-lowering genetic variants at NPC1L1 were inversely associated with coronary artery disease (OR for a genetically predicted 1-mmol/L [38.7-mg/dL] reduction in LDL-C of 0.61 [95%CI, 0.42-0.88]; P = .008) and directly associated with type 2 diabetes (OR for a genetically predicted 1-mmol/L reduction in LDL-C of 2.42 [95%CI, 1.70-3.43]; P .001). For PCSK9 genetic variants, the OR for type 2 diabetes per 1-mmol/L genetically predicted reduction in LDL-C was 1.19 (95%CI, 1.02-1.38; P = .03). For a given reduction in LDL-C, genetic variants were associated with a similar reduction in coronary artery disease risk (I2 = 0%for heterogeneity in genetic associations; P = .93). However, associations with type 2 diabetes were heterogeneous (I2 = 77.2%; P = .002), indicating gene-specific associations with metabolic risk of LDL-C-lowering alleles. CONCLUSIONS AND RELEVANCE In thismeta-analysis, exposure to LDL-C-lowering genetic variants in or near NPC1L1 and other geneswas associated with a higher risk of type 2 diabetes. These data provide insights into potential adverse effects of LDL-C-lowering therapy.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy